IL17A and colitis: On the other hand, protective effects of IL17A were ascribed to an IL17A-mediated attenuation of T-bet and IFNγ expression, leading to a more aggressive colitis upon transfer of IL17A−/− CD4 T cells into lymphopenic hosts (27).